Verified owner IgorVerified Purchase Great service, reasonable price
Animal studies show mostly mild local irritation at injection sites
While animal studies and early clinical reports are promising, its important to note that BPC-157 peptide therapy is not yet FDA-approved for weight loss or any specific medical condition, and large-scale human studies are still needed
When certain medical conditions are in play, they can completely change the game, making a structured, long-term plan necessary
Injectable Solution
NHS approach to B12 deficiency: NICE Clinical Knowledge Summaries recommend investigating B12 deficiency in patients presenting with macrocytic anaemia, unexplained neurological symptoms, or risk factors including pernicious anaemia, gastrectomy, malabsorption disorders, metformin use, proton pump inhibitors, or nitrous oxide exposure